In the DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) trial, patients with diabetes mellitus and acute myocardial infarction were randomly allocated to standard treatment plus insulin-glucose infusion for at least 24 hours followed by multidose insulin treatment or standard treatment (controls) [12]. Here, INS is linked to diabetes mellitus.